Alembic Pharmaceuticals informs about updates

13 Nov 2025 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

766.50 -2.05 (-0.27%)
23-Jan-2026 12:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1646.35
Dr. Reddys Lab 1245.10
Cipla 1381.00
Zydus Lifesciences 889.15
Lupin 2162.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×